Worth reading
91Important
Scored from 1 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.This transaction
AVision Co., Ltd.の株式取得（子会社化）Disclosing companyMedical Net,Inc.
The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.The percentage before the change is not stated in this document.
Execution Date / Effective Date2024 年３月 19 日（完了）
Target company
タイにおける POS システム開発・導入・メンテナンス事業
Location バンコク（タイ）Share capital 10,000 千バーツ（41,600 千円）Date of incorporation 2004 年９月 15 日
Procedures and assumptions
Management structure after acquisition代表取締役 Siriporn Phipatpongpan。当社49.0％、NU-DENT Co., Ltd.51.0％。NU-DENT Co., Ltd.は当社の連結子会社（孫会社）。
| Item | Details |
|---|---|
| Transaction name | AVision Co., Ltd.の株式取得（子会社化） |
| Name of the Subject Company | AVision Co., Ltd. |
| Business Description of the Subject Company | タイにおける POS システム開発・導入・メンテナンス事業 |
| Location of the Subject Company | バンコク（タイ） |
| Capital Stock of the Subject Company | 10,000 千バーツ（41,600 千円） |
| Date of Establishment of the Subject Company | 2004 年９月 15 日 |
| Voting rights ownership percentage | After 49.0％（当社）、51.0％（NU-DENT Co., Ltd.） (before not disclosed) |
| Execution Date / Effective Date | 2024 年３月 19 日（完了） |
| Management structure after acquisition | 代表取締役 Siriporn Phipatpongpan。当社49.0％、NU-DENT Co., Ltd.51.0％。NU-DENT Co., Ltd.は当社の連結子会社（孫会社）。 |
Items this document does not state (23)
Counterparty nameNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodNumber of shares acquiredFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Impact on Business PerformanceDate of board resolutionContract DateValuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to Execution
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.当社は、2024年3月14日付で公表した株式取得が完了したことを知らせているが、取得の目的や理由は本開示では説明していない。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.